image
Reviva Pharmaceuticals Holdings, Inc. RVPH
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.05
-4.81 %
$ 49.1 M
Market Cap
-1.27
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
33.30%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Reviva Pharmaceuticals Holdings, Inc.
image
RVPH has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart RVPH

image
$350.0m$350.0m$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.02022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart RVPH

image
$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)($30.0m)($30.0m)($35.0m)($35.0m)($40.0m)($40.0m)2022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart RVPH

image
$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)2022202220232023202420242025202520262026202720272028202820292029